Isolation and characterization of a monomethioninesulfoxide variant of interferon alpha-2b

被引:29
作者
Gitlin, G [1 ]
Tsarbopoulos, A [1 ]
Patel, ST [1 ]
Sydor, W [1 ]
Pramanik, BN [1 ]
Jacobs, S [1 ]
Westreich, L [1 ]
Mittelman, S [1 ]
Bausch, JN [1 ]
机构
[1] SCHERING PLOUGH CORP,RES INST,KENILWORTH,NJ 07033
关键词
protein mapping; mass spectrometry; methionine oxidation;
D O I
10.1023/A:1016059902645
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To isolate and characterize a monomethioninesulfoxide variant of the commercially available therapeutic protein interferon alpha-2b. Methods. The methionine (Met)-oxidized variant was isolated by reverse-phase high performance liquid chromatography and characterized by SDS-PAGE, peptide mapping and mass spectrometric analysis of the trypsin/V8-generated peptide fragments. The biological and immunological activities of the isolated variant were also evaluated. Results. The rHuIFN alpha-2b variant was found to contain a Met sulfoxide residue at position ill of the rHuIFN alpha-2b molecule. The far-UV CD spectra showed a slight loss of alpha-helical content and an increase in the beta-sheet contribution. The CD spectra indicate that both chromatographic conditions and Met oxidation contribute to the observed secondary structure changes. Both interferon alpha-2b main component and its methionine-oxidized variant showed different reactivity to monoclonal antibodies employed in immunoassays for the protein. Conclusions. A monomethioninesulfoxide rHuIFN alpha-2b variant was found to be present in the rHuIFN alpha-2b bulk drug substance in solution. The Met(111) residue was identified as Met sulfoxide by comparative tryptic/V8 mapping and mass spectrometric analysis. Nevertheless, the oxidation of the Met(111) residue did not seem to have a detectable effect on the biological activity of the molecule.
引用
收藏
页码:762 / 769
页数:8
相关论文
共 18 条
[1]  
BECKER GW, 1988, BIOTECHNOL APPL BIOC, V10, P326
[2]   MASS-SPECTROMETRIC DETERMINATION OF THE AMINO-ACID-SEQUENCE OF PEPTIDES AND PROTEINS [J].
BIEMANN, K ;
MARTIN, SA .
MASS SPECTROMETRY REVIEWS, 1987, 6 (01) :1-75
[3]   INTEGRATION OF MASS-SPECTROMETRY IN ANALYTICAL BIOTECHNOLOGY [J].
CARR, SA ;
HEMLING, ME ;
BEAN, MF ;
ROBERTS, GD .
ANALYTICAL CHEMISTRY, 1991, 63 (24) :2802-2824
[4]   DETERMINATION OF HELIX AND BETA-FORM OF PROTEINS IN AQUEOUS-SOLUTION BY CIRCULAR-DICHROISM [J].
CHEN, YH ;
YANG, JT ;
CHAU, KH .
BIOCHEMISTRY, 1974, 13 (16) :3350-3359
[5]  
FRELINGER AL, 1984, J BIOL CHEM, V259, P5507
[6]   THE STRUCTURE OF 8 DISTINCT CLONED HUMAN-LEUKOCYTE INTERFERON CDNAS [J].
GOEDDEL, DV ;
LEUNG, DW ;
DULL, TJ ;
GROSS, M ;
LAWN, RM ;
MCCANDLISS, R ;
SEEBURG, PH ;
ULLRICH, A ;
YELVERTON, E ;
GRAY, PW .
NATURE, 1981, 290 (5801) :20-26
[7]  
JOHNSON BA, 1989, J BIOL CHEM, V264, P14262
[8]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[9]   STABILITY OF PROTEIN PHARMACEUTICALS [J].
MANNING, MC ;
PATEL, K ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1989, 6 (11) :903-918
[10]  
NAGABHUSHAN TL, 1989, ULLMANNS ENCY IND CH, P365